174 related articles for article (PubMed ID: 36912648)
1. Evaluation of Phenotypic Tests to Detect Extended-Spectrum β-Lactamase (ESBL)-Producing Klebsiella oxytoca Complex Strains.
Campos-Madueno EI; Moser AI; Keller PM; Perreten V; Poirel L; Nordmann P; Endimiani A
J Clin Microbiol; 2023 Apr; 61(4):e0170622. PubMed ID: 36912648
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
Stürenburg E; Sobottka I; Noor D; Laufs R; Mack D
J Antimicrob Chemother; 2004 Jul; 54(1):134-8. PubMed ID: 15150168
[TBL] [Abstract][Full Text] [Related]
3. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
Mohanty S; Gaind R; Ranjan R; Deb M
J Infect Dev Ctries; 2009 Nov; 4(1):24-9. PubMed ID: 20130375
[TBL] [Abstract][Full Text] [Related]
4. Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital.
Vercauteren E; Descheemaeker P; Ieven M; Sanders CC; Goossens H
J Clin Microbiol; 1997 Sep; 35(9):2191-7. PubMed ID: 9276386
[TBL] [Abstract][Full Text] [Related]
5. Diminished Susceptibility to Cefoperazone/Sulbactam and Piperacillin/Tazobactam in
Yang F; Zhao Q; Wang L; Wu J; Jiang L; Sheng L; Zhang L; Xue Z; Yi M
Pol J Microbiol; 2022 Jun; 71(2):251-256. PubMed ID: 35716168
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.
Livermore DM; Yuan M
J Antimicrob Chemother; 1996 Sep; 38(3):409-24. PubMed ID: 8889716
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a modified double-disc synergy test for detection of extended spectrum beta-lactamases in AMPC beta-lactamase-producing proteus mirabilis.
Khan MK; Thukral SS; Gaind R
Indian J Med Microbiol; 2008; 26(1):58-61. PubMed ID: 18227600
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of extended-spectrum beta-lactamases in Enterobacter cloacae in Taiwan and comparison of 3 phenotypic confirmatory methods for detecting extended-spectrum beta-lactamase production.
Yang JL; Wang JT; Lauderdale TL; Chang SC
J Microbiol Immunol Infect; 2009 Aug; 42(4):310-6. PubMed ID: 19949754
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity and specificity of various beta-lactam antibiotics and phenotypical methods for detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases.
Bedenic B; Vranes J; Mihaljevic Lj; Tonkic M; Sviben M; Plecko V; Kalenic S
J Chemother; 2007 Apr; 19(2):127-39. PubMed ID: 17434820
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic characteristics of clinical isolates of Klebsiella pneumoniae & evaluation of available phenotypic techniques for detection of extended spectrum beta-lactamases.
Manchanda V; Singh NP; Goyal R; Kumar A; Thukral SS
Indian J Med Res; 2005 Oct; 122(4):330-7. PubMed ID: 16394326
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime.
Jang W; Park YJ; Park KG; Yu J
J Antimicrob Chemother; 2013 Oct; 68(10):2282-5. PubMed ID: 23671215
[TBL] [Abstract][Full Text] [Related]
13. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.
Steward CD; Rasheed JK; Hubert SK; Biddle JW; Raney PM; Anderson GJ; Williams PP; Brittain KL; Oliver A; McGowan JE; Tenover FC
J Clin Microbiol; 2001 Aug; 39(8):2864-72. PubMed ID: 11474005
[TBL] [Abstract][Full Text] [Related]
14. [Effect of inoculum size on sensitivity and specificity of the double-disk synergy test for the detection of wide-spectrum beta-lactamases].
Bedenić B; Boras A
Lijec Vjesn; 2001; 123(11-12):293-6. PubMed ID: 11930754
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide.
Drieux L; Brossier F; Sougakoff W; Jarlier V
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():90-103. PubMed ID: 18154532
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of different phenotypic methods detecting extended spectrum beta-lactamases in Pseudomonas aeruginosa and Acinetobacter baumannii strains].
Zarakolu P; Metan G; Hasçelik G; Akova M
Mikrobiyol Bul; 2005 Jul; 39(3):265-72. PubMed ID: 16358485
[TBL] [Abstract][Full Text] [Related]
17. Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotype.
Sader HS; Hsiung A; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):341-4. PubMed ID: 17141461
[TBL] [Abstract][Full Text] [Related]
18. Use of boronic acid disk tests to detect extended- spectrum beta-lactamases in clinical isolates of KPC carbapenemase-possessing enterobacteriaceae.
Tsakris A; Poulou A; Themeli-Digalaki K; Voulgari E; Pittaras T; Sofianou D; Pournaras S; Petropoulou D
J Clin Microbiol; 2009 Nov; 47(11):3420-6. PubMed ID: 19726597
[TBL] [Abstract][Full Text] [Related]
19. Extended-spectrum β-lactamase- producing gram-negative bacterial infections in severely ill COVID-19 patients admitted in a national referral hospital, Kenya.
Mutua JM; Njeru JM; Musyoki AM
Ann Clin Microbiol Antimicrob; 2023 Oct; 22(1):91. PubMed ID: 37838665
[TBL] [Abstract][Full Text] [Related]
20. Contemporary diversity of β-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent β-lactamase groups.
Castanheira M; Farrell SE; Krause KM; Jones RN; Sader HS
Antimicrob Agents Chemother; 2014; 58(2):833-8. PubMed ID: 24247134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
